These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6571261)

  • 1. Severe acute polyarthropathy associated with levamisole therapy in a patient with Crohn's disease.
    Benfield GF; Felix-Davies DD; Thompson RA; Asquith P
    Eur J Rheumatol Inflamm; 1984; 7(2):63-5. PubMed ID: 6571261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Side effect of levamisole during Crohn's disease].
    Dupas JL; Capron JP; Delamarre J; Lorriaux A
    Nouv Presse Med; 1979 Apr; 8(16):1350-1. PubMed ID: 482107
    [No Abstract]   [Full Text] [Related]  

  • 3. [Secondary effects of levamisole in Crohn's disease].
    Villand J; Carli H
    Nouv Presse Med; 1979 Nov; 8(45):3753. PubMed ID: 534237
    [No Abstract]   [Full Text] [Related]  

  • 4. Levamisole-induced arthritis in Crohn's disease.
    Segal AW; Pugh SF; Levi AJ; Loewi G
    Br Med J; 1977 Aug; 2(6086):555. PubMed ID: 890414
    [No Abstract]   [Full Text] [Related]  

  • 5. Levamisole induced granulocytopenia and thrombocytopenia in a case of Crohn's colitis.
    Sategna-Guidetti C; Peyre S
    Gastroenterol Clin Biol; 1979 Jan; 3(1):104. PubMed ID: 437394
    [No Abstract]   [Full Text] [Related]  

  • 6. Defective neutrophil chemotaxis corrected by levamisole in Crohn's disease.
    Patrone F; Dallegri F; Sacchetti C
    Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):322-3. PubMed ID: 696210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Crohn's disease of the colon treated with high doses of levamisole].
    Tixier P; Verger JB; Rabia M; Bardeche P; Brodi L
    Nouv Presse Med; 1978 Dec; 7(43):3942. PubMed ID: 733561
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases.
    Weersma RK; Peters FT; Oostenbrug LE; van den Berg AP; van Haastert M; Ploeg RJ; Posthumus MD; Homan van der Heide JJ; Jansen PL; van Dullemen HM
    Aliment Pharmacol Ther; 2004 Oct; 20(8):843-50. PubMed ID: 15479355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic monoarticular arthritis and acute pericardial tamponade in a child with Crohn's disease.
    Van Gundy ET; Kaufman SS; Danford DA; Pilley MD; Perry DA
    J Rheumatol; 1993 Dec; 20(12):2140-2. PubMed ID: 8014945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary effects of levamisole in Crohn disease].
    Villand J; Carli H
    Nouv Presse Med; 1979 Oct; 8(40):3271. PubMed ID: 534191
    [No Abstract]   [Full Text] [Related]  

  • 11. [Letter: Crohn's disease and levamisole].
    Bertrand J; Renoux G; Renoux M; Palat A
    Nouv Presse Med; 1974 Oct; 3(35):2265. PubMed ID: 4617861
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum sickness associated with 6-mercaptopurine in a patient with Crohn's disease.
    Andersen JM; Tiede JJ
    Pharmacotherapy; 1997; 17(1):173-6. PubMed ID: 9017780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metronidazole therapy for Crohn's disease and associated fistulae.
    Jakobovits J; Schuster MM
    Am J Gastroenterol; 1984 Jul; 79(7):533-40. PubMed ID: 6741906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated?
    Domènech E; Hinojosa J; Nos P; Garcia-Planella E; Cabré E; Bernal I; Gassull MA
    Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1107-13. PubMed ID: 16305724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levamisole in Crohn's disease--a double-blind controlled trial.
    Wesdorp E; Schellekens PT; Weening RS; Meuwissen SG; Tytgat GN
    Digestion; 1978; 18(3-4):186-91. PubMed ID: 367851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab retreatment in adults and children with Crohn's disease: risk factors for the development of delayed severe systemic reaction.
    Kugathasan S; Levy MB; Saeian K; Vasilopoulos S; Kim JP; Prajapati D; Emmons J; Martinez A; Kelly KJ; Binion DG
    Am J Gastroenterol; 2002 Jun; 97(6):1408-14. PubMed ID: 12094858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin.
    Prantera C; Berto E; Scribano ML; Falasco G
    Ital J Gastroenterol Hepatol; 1998 Dec; 30(6):602-6. PubMed ID: 10076781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infliximab therapy in children and adolescents with refractory Crohn's disease in the Netherlands; experience with 23 patients].
    de Ridder L; Escher JC; Taminiau JA
    Ned Tijdschr Geneeskd; 2002 Oct; 146(40):1879-83. PubMed ID: 12395595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Crohn's disease and ascites].
    Aparicio Tormo JR; Laveda R; Gómez Andrés A
    Gastroenterol Hepatol; 2000 Oct; 23(8):384-8. PubMed ID: 11227652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.